Found: 29
Select item for more details and to access through your institution.
Bisphosphonates associated osteonecrosis of the jaw: A long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over time.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 12, p. 850, doi. 10.1002/ajh.21553
- By:
- Publication type:
- Article
Interferon Alpha Has a Strong Anti-tumor Effect in Philadelphia-negative Myeloproliferative Neoplasms.
- Published in:
- 2019
- By:
- Publication type:
- journal article
90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 1, p. 1, doi. 10.1111/j.1365-2141.2011.08802.x
- By:
- Publication type:
- Article
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Rapid reversion of eosinophilic gastroenteritis associated with FIP1L1-PDGFRA fusion after targeted therapy with imatinib.
- Published in:
- 2006
- By:
- Publication type:
- Other
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report.
- Published in:
- British Journal of Haematology, 2004, v. 127, n. 5, p. 477, doi. 10.1111/j.1365-2141.2004.05206.x
- By:
- Publication type:
- Article
correspondence Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma.
- Published in:
- 2004
- By:
- Publication type:
- Letter
IMAGES IN HAEMATOLOGY Disseminated molluscum contagiosum in a patient with chronic lymphocytic leukaemia after alemtuzumab.
- Published in:
- 2003
- By:
- Publication type:
- Other
An unusual presentation of schistosomiasis.
- Published in:
- British Journal of Haematology, 2003, v. 121, n. 1, p. 2, doi. 10.1046/j.1365-2141.2003.04156.x
- By:
- Publication type:
- Article
Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
- Published in:
- Oncologist, 2016, v. 21, n. 9, p. 1107, doi. 10.1634/theoncologist.2016-0103
- By:
- Publication type:
- Article
Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?
- Published in:
- Acta Oncologica, 2015, v. 54, n. 6, p. 953, doi. 10.3109/0284186X.2015.1027410
- By:
- Publication type:
- Article
Circulating mitotic figures in a patient with dual infection by Epstein-Barr virus and cytomegalovirus.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 1, p. 89, doi. 10.1111/ejh.12132
- By:
- Publication type:
- Article
An accessory spleen wrongly recognised as relapse by positron emission tomography.
- Published in:
- 2006
- By:
- Publication type:
- Other
Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent.
- Published in:
- Agriculture & Food Security, 2016, v. 5, p. 1, doi. 10.1186/s40164-015-0030-1
- By:
- Publication type:
- Article
Emerging markers of cachexia predict survival in cancer patients.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Emerging markers of cachexia predict survival in cancer patients.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-828
- By:
- Publication type:
- Article
Emerging markers of cachexia predict survival in cancer patients.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-828
- By:
- Publication type:
- Article
STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- letter
Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma.
- Published in:
- Case Reports in Hematology, 2012, p. 1, doi. 10.1155/2012/803298
- By:
- Publication type:
- Article
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2008, v. 90, n. 1, p. 31, doi. 10.1007/s11060-008-9623-4
- By:
- Publication type:
- Article
Extramedullary plasmacytoma presented as a non-functional invasive pituitary macro-adenoma.
- Published in:
- Journal of Neuro-Oncology, 2008, v. 88, n. 2, p. 227, doi. 10.1007/s11060-008-9558-9
- By:
- Publication type:
- Article
Salvage therapy for primary central nervous system lymphoma with <sup>90</sup>Y-Ibritumomab and Temozolomide.
- Published in:
- Journal of Neuro-Oncology, 2007, v. 83, n. 3, p. 291, doi. 10.1007/s11060-006-9324-9
- By:
- Publication type:
- Article
Efficacy and Safety of Bortezomib in Patients With Plasma Cell Leukemia.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 11, p. 2285, doi. 10.1002/cncr.22700
- By:
- Publication type:
- Article
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 6, p. 1332, doi. 10.1002/cncr.21314
- By:
- Publication type:
- Article
Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
- Published in:
- 2004
- By:
- Publication type:
- letter
Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 12, p. 2900, doi. 10.1002/cncr.20704
- By:
- Publication type:
- Article